Frontpage Mental & Physical health Chronic diseases Cancer

Get the newest information about «Cancer»

How often would you like to receive alerts from fhi.no? (This affects all your alerts)

As soon as new content is published
Daily
Weekly

You will only receive an alert if new information was published since you received one.

The email address you register will only be used to send you these alerts. You can cancel your alerts and delete your email address at any time by following the link in the alerts you receive.
Read more about the privacy policy for fhi.no

You have subscribed to alerts about:

Cancer

Cancer

Many environmental factors can influence cancer incidence. Genes also play a role. However, the causes of many types of cancer are still unknown.

Les på norsk

From NCD report

Indicators for Non-Communicable Diseases (NCD)

Cancer incidence (Indicator 2)

The indicator describes the following: cancer incidence, by type of cancer, per 100 000 person years.

Updated 05.10.2022

Indicators for Non-Communicable Diseases (NCD)

Palliative cancer care (Indicator 20)

The indicator describes the following: Access to palliative care assessed by morphine-equivalent consumption of strong opioid analgesics (in grams of morphine) per death from cancer.

Updated 04.11.2022

Reports

Health technology assessment

Treatments for relapsing and/or refractory multiple myeloma

The Norwegian Institute of Public Health (NIPH) was commissioned by the RHA forum to perform a full health technology assessment on the pharmacological treatment of multiple myeloma.

Published 23.03.2023

Systematic review

Treatment for localized prostate cancer: a rapid review for patient decision aid (update)

In this rapid review, the purpose was to update the knowledge base for the joint selection tool for the treatment of prostate cancer without spread.

Published 16.03.2023

Systematic review

HPV-testing in the screening program for cervical cancer of the 25 to 33 age group

The purpose of this systematic review was to evaluate the effect of three screening strategies for women below 34 years.

Published 29.08.2022

Health technology assessment

Molecular tests for detection of PIK3CA mutations in men and postmenopausal women with HR+/HER2–, locally advanced or metastatic breast cancer

The Norwegian Institute of Public Health was commissioned to evaluate molecular tests for the identification of somatic PIK3CA mutations in men and postmenopausal women with HR+/HER2–, advanced or met...

Published 28.03.2022

Health technology assessment

Tests for the detection of NTRK gene fusions in patients with locally advanced or metastatic solid tumours

The Norwegian Institute of Public Health has been commissioned to assess molecular tests for the identification of NTRK gene fusions in locally advanced or metastatic solid tumours.

Published 06.01.2022

Health technology assessment

Tests for detection of ROS1 gene alterations in people with non-small cell lung cancer (NSCLC)

The Norwegian Institute of Public Health has been commissioned to evaluate molecular tests for the identification of somatic ROS1 gene alterations in people with locally advanced or metastatic non-sma...

Published 10.11.2021

Health technology assessment

Evaluation of PD-L1 assays in urothelial carcinoma

The Ordering Forum (Bestillerforum for nye metoder) commissioned the Norwegian Institute of Public Health to evaluate commercial PD-L1 tests for use in treatment of urothelial carcinoma.

Published 17.08.2021

Mapping review

Personalized medicine and public health: research syntheses mapping

This report seeks to explore the interface between personalized medicine and public health.

Published 06.07.2021

Health technology assessment

Hydrogel rectal spacer SpaceOAR™ in prostate cancer radiation therapy

We were commissioned to perform a health technology assessment of SpaceOAR™ hydrogel for prevention of radiation-induced side effects following treatment for prostate cancer.

Published 10.02.2021

Research findings

As many large breast tumours detected without mammography
Nordic twin study highlights familial cancer risk

Projects

Influenza in pregnancy and cancer in children
15.03.23
Childhood cancer and prenatal environmental exposures
15.03.23
Disease in the mother and the risk of leukemia in children
14.12.22
Health technology assessment of 177Lu- PSMA-617 treatment for metastatic castration resistant prostate cancer - Protocol for Health technology assessment
25.11.22
Transperineal biopsy compared with transrectal biopsy in suspected prostate cancer - Protocol for Health Technology Assessment
01.06.21

See all